By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PsiOxus Therapeutics Limited 

Cherwell Innovation Centre
Unit 77, Heyford Park
Upper Heyford  Oxfordshire  OX25 5HD  United Kingdom
Phone: 44-(0)1869-238069 Fax: 44-(0)1869-238001



Company News
PsiOxus Therapeutics Limited Release: European Medicines Agency Grants Positive Opinion For Orphan Drug Status For Ovarian Cancer Oncolytic Vaccine 1/13/2015 11:01:11 AM
PsiOxus Therapeutics Limited Select BioOutsource To Support Clinical Sample Analysis For OCTAVE Ovarian Cancer Study 6/19/2014 9:10:34 AM
PsiOxus Therapeutics Limited Initiates "OCTAVE" Ovarian Cancer Study For Oncolytic Vaccine Enadenotucirev 6/17/2014 11:24:18 AM
PsiOxus Therapeutics Limited Announces Positive Study Results Of Oncolytic Vaccine Enadenotucirev At 2014 American Society of Clinical Oncology Annual Meeting 6/3/2014 6:45:40 AM
PsiOxus Therapeutics Limited To Release Study Results Of Oncolytic Vaccine Enadenotucirev In Cancer Patients 5/13/2014 8:44:44 AM
PsiOxus Therapeutics Limited Cancer-Wasting Drug Better Than Placebo In Phase 2 Study 11/12/2013 8:54:49 AM
BioIndustry Association Congratulates UK Company PsiOxus Therapeutics Limited on Being Named EuropaBio's Most Innovative European Biotech SME 10/3/2013 9:36:39 AM
PsiOxus Therapeutics Limited Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102 3/4/2013 10:30:04 AM
DTRA Awards $3.3 Million Contract to PsiOxus Therapeutics Limited to Develop Biodefence Vaccine Adjuvants 1/16/2013 9:08:14 AM
IXICO and PsiOxus Therapeutics Limited Win Significant Funding From Government-Backed Biomedical Catalyst 11/5/2012 3:25:16 PM